Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

erlotinib

erlotinib
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Tarceva TABLET, ORAL 100 mg, 150 mg      
VIEW MORE Antineoplastic Agents
CLASS
100000
Comments:

At Huntsville Main/W&C/Madison, orders for this medication should be rejected and reviewed by an oncology clinical specialist or an oncology pool member (see second page of the document "Hormone Therapies and Guidance on Oral Chemotherapy") 

Oral Chemotherapy Drug Pharmacist Education

Oral Chemotherapy TOC Information

Restricted to oncology. Not routinely stocked, but obtained if needed; the patient may also be encouraged to use his/her home supply.

Reviewed: July 27, 2005

Last updated: Mar. 5, 2025






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2025 Rpharmy, LLC ­ All Rights Reserved